There’s been no escaping the controversy over Gardasil, the FDA-approved vaccine for cervical cancer.
If made available and affordable, Gardasil could all but eradicate cervical cancer, which kills 4,000 American women, and a quarter-million women worldwide, every year.
But opposition to this valuable treatment regimen is mounting, largely due to perceptions that it is cost-prohibitive.
But a dollar in prevention is worth a million dollars in cures.
At $360, the three-shot regimen is admittedly more expensive than many vaccines, since it is not always covered by insurance.
But these costs pale in comparison to the expense of treating cervical cancer.
If they are wise, public and private insurers will invest in Gardasil and cover universal vaccinations.
If they don’t, they will pay for it in the long run, when they are forced to insure treatment for thousands more women with cervical cancer.
This is Dr. Bruce Feinberg. Be well.
Page Updated: 05/23/07, 10:32 AM